Global sales information and US Prescriptions data of 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one obtained from Centers for Medicare & Medicaid Services Website
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**